A Study on Functional Connectome and rTMS Intervention of Cognitive Flexibility Impairment in Patients With Major Depressive Disorder
NCT07161492 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 182
Last updated 2025-09-08
Summary
Persistent cognitive impairment in major depressive disorder (MDD) affects both treatment outcomes and psychosocial functioning, emphasizing the critical need for effective treatment. However, there is still a lack of effective treatment at present. Our previous studies found that the impairment in cognitive flexibility (CF) persisted even in remitted patients with MDD. This impairment was correlated with hypo-connectivity between the left inferior parietal lobule (IPL) and the right dorsal prefrontal cortex (dPFC). Based on these findings, we hypothesize that the hypo-connectivity between the left IPL and the right dPFC is the neural basis of CF impairment, and targeted interventions of this connection may alleviate CF impairment and thus improve treatment outcomes as well as psychosocial functioning of patients with MDD. The present study proposes to employ cognitive training for MDD patients with CF impairment. By comparing changes in CF and brain functional connectivity via task-based fMRI before and after the intervention, we aim to clarify the effect of cognitive training on cognitive performance, treatment outcomes and psychosocial functioning, and identify the critical role of the hypo-connectivity between the left IPL and the right dPFC underlying CF impairment. Furthermore, we will conduct a randomized controlled trial to investigate the effect of individualized dual-target repetitive transcranial magnetic stimulation (rTMS) on CF by targeting the hypo connectivity between the left IPL and the right dPFC. The results will further validate the critical role of this connection in modulating CF performance and provide a reliable intervention target for reducing CF impairment.
Conditions
- Depressive Disorder, Major
- Cognitive Impairment
Interventions
- DEVICE
-
Repetitive Transcranial Magnetic Stimulation
Individualized dual-target rTMS delivered using MRI-guided neuronavigation (Dolphin Robotics). Stimulation parameters: * Targets: Left IPL and right dPFC connectivity hotspots * Protocol: 100 pulse-pairs/session at 0.2Hz * Intensities: Conditioning stimulus 90% RMT, test stimulus 120% RMT * Duration: 8.3 min/session, 5 sessions/week × 4 weeks
- BEHAVIORAL
-
Computerized Cognitive Remediation Therapy
Structured computer-based training targeting cognitive flexibility, consisting of 4-6 exercises per session. Each exercise includes 8-24 progressively challenging tasks. Administered for 45-60 minutes per session, 5 sessions/week over 4 weeks. Delivered via specialized software on desktop computers.
- DEVICE
-
Sham Repetitive Transcranial Magnetic Stimulation
Inactive stimulation using identical equipment with: * Coil tilted at 90° to scalp * Magnetic shielding insert * Matched acoustic artifact All other parameters identical to active rTMS arm.
- DRUG
-
Selective Serotonin Reuptake Inhibitors or Serotonin-Norepinephrine Reuptake Inhibitors
Background antidepressant therapy maintained at stable doses throughout the study. Minimum dose requirements: * SSRIs: Paroxetine ≥20mg/day, Sertraline ≥50mg/day * SNRIs: Venlafaxine ≥75mg/day, Duloxetine ≥60mg/day Dosage adjustments prohibited during trial participation.
Sponsors & Collaborators
-
Second Xiangya Hospital of Central South University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-09-30
- Primary Completion
- 2028-08-31
- Completion
- 2028-10-31
Countries
- China
Study Locations
More Related Trials
-
Electroencephalography-based Precise Repetitive Transcranial Magnetic Stimulation Treatment
NCT06385405 ·Status: RECRUITING ·Phase: NA
-
REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN the Treatment of DEPRESSION
NCT00220610 ·Status: UNKNOWN ·Phase: PHASE2
-
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia
NCT00783120 ·Status: COMPLETED ·Phase: NA
-
Functional Brain Imaging Study of Response to Repetitive TMS (rTMS) Treatment of Major Depression
NCT01768052 ·Status: UNKNOWN
-
To Investigate the Change of Brain and Autonomic Function From Different Protocols of Repeated Transcranial Magnetic Stimulation Therapy for Patients With Post-traumatic Stress Disorder Comorbid Major Depressive Disorder
NCT07327385 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Study About Mechanism of Transcranial Magnetic Stimulation Treatment of Depression Using Medical Imaging
NCT03500029 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of rTMS for Cognitive Deficits in Chronic Patients With Schizophrenia
NCT03273439 ·Status: COMPLETED ·Phase: NA
-
Neural Mechanisms of Temporal Interference Stimulation on Improving Social Reward Function in Depression
NCT07287878 ·Status: RECRUITING ·Phase: NA
-
rTMS-induced Cumulative Pattern of sBDNF in Chronic Schizophrenia
NCT01427088 ·Status: COMPLETED ·Phase: NA
-
Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients
NCT01370291 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Magnetic Resonance Imaging-guided Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression: A Randomized, Double-Blind, Controlled Pilot Study
NCT07185438 ·Status: RECRUITING ·Phase: NA
-
Intensive Transcranial Magnetic Stimulation for Negative Symptoms in Schizophrenia
NCT02127879 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Depression
NCT01516931 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder
NCT06782763 ·Status: RECRUITING ·Phase: NA
-
Deep Transcranial Magnetic Stimulation for the Treatment of Treatment Resistance Schizophrenia
NCT04478032 ·Status: UNKNOWN ·Phase: NA
-
Clinical Effect of dTMS in Major Depressive Disorder
NCT03265340 ·Status: COMPLETED ·Phase: NA
-
Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery
NCT06482749 ·Status: RECRUITING ·Phase: NA
-
Dorsomedial Prefrontal Neuromodulation in Treatment-resistant Depression
NCT05422417 ·Status: RECRUITING ·Phase: NA
-
Targeting Specific Brain Networks to Treat Specific Symptoms in Depression
NCT05523817 ·Status: RECRUITING ·Phase: NA
-
rTMS in the Prevention and Treatment of Postoperative Executive Dysfunction
NCT05575583 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Repetitive Transcranial Magnetic Stimulation in Depressed Patients
NCT02213016 ·Status: UNKNOWN ·Phase: PHASE4
-
Deep-brain Magnetic Stimulation (DMS) in the Treatment of Major Depressive Disorder
NCT02184221 ·Status: COMPLETED ·Phase: NA
-
Treating Refractory Major Depressive Disorder With Repetitive Transcranial Magnetic Stimulation
NCT00305045 ·Status: COMPLETED ·Phase: NA
-
A Study of Repetitive Transcranial Magnetic Stimulation in Bipolar Patients
NCT03207048 ·Status: COMPLETED ·Phase: NA
-
Exploration of the Deep Transcranial Magnetic Stimulation for Treatment Resistant Schizophrenia
NCT05167942 ·Status: UNKNOWN ·Phase: NA